Published in Am J Gastroenterol on July 01, 1996
Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis. Dig Dis Sci (2008) 1.65
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg (2000) 1.22
Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer (2004) 1.15
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol (2006) 1.07
Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer. Clin Exp Med (2010) 1.02
C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J Gastroenterol (2004) 1.01
Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Br J Cancer (1999) 0.96
Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br J Cancer (1997) 0.96
Reduced hemoglobin and increased C-reactive protein are associated with upper gastrointestinal bleeding. World J Gastroenterol (2014) 0.93
Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. Neuro Oncol (2007) 0.89
Serum biomarker panels for the diagnosis of gastric adenocarcinoma. Br J Cancer (2012) 0.89
Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) mice. Dig Dis Sci (2008) 0.87
Platelets and inflammatory markers in patients with gastric cancer. Clin Dev Immunol (2013) 0.86
The -174 G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan. J Clin Immunol (2009) 0.83
Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection. Dig Dis Sci (2009) 0.83
Retinol-binding protein, acute phase reactants and Helicobacter pylori infection in patients with gastric adenocarcinoma. World J Gastroenterol (2005) 0.80
Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer. Sci Rep (2016) 0.80
Assessment of platelet activation and phagocytic activity in gastric cancer patients. World J Gastrointest Pathophysiol (2013) 0.78
Remodeling of the immunoinflammatory network system in elderly cancer patients: implications of inflamm-aging and tumor-specific hyperinflammation. Surg Today (2008) 0.78
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis. Oncoimmunology (2016) 0.78
Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients. Gastroenterol Res Pract (2015) 0.78
Interleukin 1β-A Potential Salivary Biomarker for Cancer Progression? Biomark Cancer (2015) 0.77
A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying. PLoS One (2017) 0.75
Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer. Eurasian J Med (2014) 0.75
Local Immune Response in Helicobacter pylori Infection. Medicine (Baltimore) (2016) 0.75
Association between Serum Levels of Interleukin-6 and Stage of Laryngeal Cancer. Iran J Otorhinolaryngol (2015) 0.75
Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Up-regulation of beta-actin, cyclophilin and GAPDH in N1S1 rat hepatoma. Oncol Rep (1998) 7.75
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res (1996) 6.03
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med (1997) 6.03
Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res (2000) 2.91
Isolation and characterization of a glucosamine-requiring mutant of Escherichia coli K-12 defective in glucosamine-6-phosphate synthetase. J Bacteriol (1971) 2.80
Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia. J Clin Microbiol (1985) 2.68
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest (2001) 2.61
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol (2008) 2.60
Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem J (2000) 2.58
The location and structure of double-strand DNA breaks induced during yeast meiosis: evidence for a covalently linked DNA-protein intermediate. EMBO J (1995) 2.54
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology (1998) 2.52
Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol (1998) 2.50
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol (2011) 2.41
Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg (1996) 2.35
Moderate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilities. J Neurosci (2007) 2.31
Use of a recombination reporter insert to define meiotic recombination domains on chromosome III of Saccharomyces cerevisiae. Mol Cell Biol (1999) 2.22
Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet (1973) 2.22
Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery (2000) 2.14
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin Pharmacol Ther (2010) 2.13
Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem (1999) 1.94
Chemical characterization of a new surface antigenic polysaccharide from a mutant of Staphylococcus aureus. J Bacteriol (1971) 1.86
Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med (2000) 1.80
A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. Clin Cancer Res (2009) 1.79
Evaluation of the usefulness of counterimmunoelectrophoresis for diagnosis of Clostridium difficile-associated colitis in clinical specimens. J Clin Microbiol (1983) 1.78
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res (2001) 1.75
Evaluation of three bacteriuria screening methods in a clinical research hospital. J Clin Microbiol (1985) 1.73
Sonography of acute right side colonic diverticulitis. Am J Surg (2001) 1.70
Comparison of lysis-centrifugation with lysis-filtration and a conventional unvented bottle for blood cultures. J Clin Microbiol (1984) 1.67
Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer (1995) 1.66
Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int (2000) 1.66
Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer (2004) 1.64
Results of curative gastrectomy for carcinoma of the distal third of the stomach. J Am Coll Surg (1996) 1.64
Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. Hum Gene Ther (1999) 1.63
Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol (1995) 1.58
Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen. J Clin Microbiol (1983) 1.58
Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg (1995) 1.58
Autoantibody response to heat shock protein 70 in patients with heatstroke. Am J Med (2001) 1.57
Effects and limitations of prolonged intermittent ischaemia for hepatic resection of the cirrhotic liver. Br J Surg (1996) 1.55
Histamine suppression of human lymphocyte responses to mitogens. Cell Immunol (1978) 1.48
Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. Clin Pharmacol Ther (2001) 1.46
Improving DNA vaccine potency via modification of professional antigen presenting cells. Curr Opin Mol Ther (2003) 1.45
Identification of vacuolar serine proteinase as a major allergen of Aspergillus fumigatus by immunoblotting and N-terminal amino acid sequence analysis. Clin Exp Allergy (2001) 1.45
Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients. J Gastroenterol (1998) 1.42
Randomized trial of gastrojejunostomy with duodenal partition versus antrectomy in unresectable periampullary cancer. Zhonghua Yi Xue Za Zhi (Taipei) (2001) 1.41
Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. Gene Ther (2000) 1.41
Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol Cell Biol (1983) 1.39
Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. Int J Cancer (1998) 1.38
Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J Surg (2000) 1.37
Heterotopic pancreas: a difficult diagnosis. J Clin Gastroenterol (1999) 1.37
Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms. Ann Surg (1996) 1.36
Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology (1992) 1.35
Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA (2000) 1.33
Monoclonal antibodies to laminin reveal the heterogeneity of basement membranes in the developing and adult mouse tissues. J Cell Biol (1984) 1.33
Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology (1999) 1.33
Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol (2002) 1.33
Mesenteric and omental cysts: an ultrasonographic and clinical study of 15 patients. Gastrointest Radiol (1991) 1.32
Demonstration of papillomavirus capsid antigen in human conjunctival neoplasia. Arch Ophthalmol (1986) 1.28
Analysis of hepatitis B virus transcripts in infected human livers. Hepatology (1989) 1.25
The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev (1994) 1.23
Evaluation of a commercial kit for the routine detection of Clostridium difficile cytotoxin by tissue culture. J Clin Microbiol (1986) 1.23
Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut (1996) 1.23
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg (2000) 1.22
Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study. Dig Dis Sci (1992) 1.21
Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. Eur J Clin Invest (2006) 1.20
Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. Am J Kidney Dis (1997) 1.20
IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int (2001) 1.19
Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedure. J Am Coll Surg (1999) 1.19
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. World J Surg (2000) 1.19
Experimental vaccine strategies for cancer immunotherapy. J Biomed Sci (1998) 1.18
Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis (1996) 1.16
A cluster of Acinetobacter Pneumonia in foundry workers. Ann Intern Med (1981) 1.16
Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension (1997) 1.16
Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1. J Biol Chem (2001) 1.14
Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int J Cancer (1998) 1.13
A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. Cancer Res (1993) 1.12
Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function? Surgery (1996) 1.11
Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol (1994) 1.11
Laparoscopic cholecystectomy for cholelithiasis in a patient with situs inversus totalis. Endoscopy (1992) 1.11
Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav (1991) 1.10
Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells. J Am Coll Surg (1997) 1.09
Prospective comparison of diagnostic peritoneal lavage, computed tomographic scanning, and ultrasonography for the diagnosis of blunt abdominal trauma. J Trauma (1993) 1.09
Immunohistochemical localization of entactin and laminin in mouse embryos and fetuses. Dev Biol (1983) 1.08
Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen. J Immunol (2001) 1.08
Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines. Vaccine (2000) 1.08
Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay. Cancer Epidemiol Biomarkers Prev (1996) 1.08
Accumulation of mitochondrial DNA deletions in human oral tissues -- effects of betel quid chewing and oral cancer. Mutat Res (2001) 1.07
Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer (2000) 1.07